Fund shareholders of Alumis Inc
ISIN US0223071020 · United States
- Fund shareholders
- 181
- Of which ETFs
- 39 142 other funds
- Value held
- 435.2M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 3,028,203 | 66.7M $ | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares Russell 2000 ETF iShares Trust | 1,671,416 | 36.8M $ | 0.05 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 1,188,623 | 26.2M $ | 0.24 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 906,133 | 20M $ | 0.02 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 678,061 | 16.7M $ | 0.05 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 667,220 | 14.7M $ | 0.12 % | as of Mar 31, 2026 ↗ |
| iShares Russell 2000 Value ETF iShares Trust | 587,287 | 12.9M $ | 0.10 % | as of Mar 31, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 561,900 | 16.7M $ | 0.31 % | as of Feb 28, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 530,358 | 11.7M $ | 0.14 % | as of Mar 31, 2026 ↗ |
| Invesco Main Street Small Cap Fund AIM Growth Series (Invesco Growth Series) | 474,189 | 10.4M $ | 0.47 % | as of Mar 31, 2026 ↗ |
| SmallCap Fund Principal Funds, Inc | 421,500 | 10.4M $ | 0.50 % | as of Apr 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 413,552 | 12.3M $ | 0.03 % | as of Feb 28, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 386,109 | 11.5M $ | 0.06 % | as of Feb 28, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 330,600 | 8.2M $ | 0.43 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 329,100 | 7.3M $ | 0.09 % | as of Mar 31, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 293,662 | 8.7M $ | 0.13 % | as of Feb 27, 2026 ↗ |
| VANGUARD RUSSELL 2000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 280,046 | 8.3M $ | 0.05 % | as of Feb 28, 2026 ↗ |
| Invesco V.I. Main Street Small Cap Fund AIM Variable Insurance Funds (Invesco Variable Insurance Funds) | 251,866 | 5.5M $ | 0.47 % | as of Mar 31, 2026 ↗ |
| Fidelity Enhanced Small Cap ETF Fidelity Covington Trust | 232,229 | 5.1M $ | 0.12 % | as of Mar 31, 2026 ↗ |
| iShares U.S. Pharmaceuticals ETF iShares Trust | 226,551 | 5M $ | 0.50 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF SPDR SERIES TRUST | 224,127 | 4.9M $ | 1.60 % | as of Mar 31, 2026 ↗ |
| Royce Small-Cap Fund ROYCE FUND | 188,696 | 4.2M $ | 0.23 % | as of Mar 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 172,888 | 3.8M $ | 0.31 % | as of Mar 31, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 160,321 | 4.8M $ | 0.02 % | as of Feb 28, 2026 ↗ |
| Fidelity Advisor Health Care Fund Fidelity Advisor Series VII | 150,700 | 3.7M $ | 0.13 % | as of Apr 30, 2026 ↗ |
| Schwab Small-Cap Index Fund SCHWAB CAPITAL TRUST | 150,561 | 3.7M $ | 0.05 % | as of Apr 30, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 147,373 | 4.4M $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Invesco Dorsey Wright SmallCap Momentum ETF Invesco Exchange-Traded Fund Trust II | 129,155 | 3.8M $ | 0.99 % | as of Feb 28, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 124,101 | 3.1M $ | 0.11 % | as of Apr 30, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 117,376 | 3.5M $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Master Small Cap Index Series Quantitative Master Series LLC | 111,384 | 2.5M $ | 0.05 % | as of Mar 31, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 109,761 | 2.4M $ | 0.00 % | as of Mar 31, 2026 ↗ |
| MassMutual Small Cap Opportunities Fund MASSMUTUAL PREMIER FUNDS | 107,993 | 2.4M $ | 0.47 % | as of Mar 31, 2026 ↗ |
| Invesco Dorsey Wright Healthcare Momentum ETF Invesco Exchange-Traded Fund Trust | 103,872 | 2.6M $ | 2.12 % | as of Apr 30, 2026 ↗ |
| College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund | 93,864 | 2.1M $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Discovery Fund Fidelity Concord Street Trust | 91,800 | 2.3M $ | 0.10 % | as of Apr 30, 2026 ↗ |
| VANGUARD U.S. MOMENTUM FACTOR ETF VANGUARD WELLINGTON FUND | 85,602 | 2.5M $ | 0.18 % | as of Feb 28, 2026 ↗ |
| Fidelity Small Cap Value Index Fund Fidelity Salem Street Trust | 84,874 | 1.9M $ | 0.10 % | as of Mar 31, 2026 ↗ |
| Optimum Small-Mid Cap Growth Fund Optimum Fund Trust | 82,551 | 1.8M $ | 0.24 % | as of Mar 31, 2026 ↗ |
| Nuveen Small Cap Blend Index Fund TIAA-CREF Funds | 82,076 | 2M $ | 0.05 % | as of Apr 30, 2026 ↗ |
| Fidelity Series Small Cap Discovery Fund Fidelity Concord Street Trust | 80,600 | 2M $ | 0.10 % | as of Apr 30, 2026 ↗ |
| JPMorgan Small Cap Value Fund JPMorgan Trust II | 77,546 | 1.7M $ | 0.15 % | as of Mar 31, 2026 ↗ |
| VictoryShares US Small Mid Cap Value Momentum ETF Victory Portfolios II | 74,513 | 1.6M $ | 0.12 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 74,496 | 2.2M $ | 0.01 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 72,447 | 1.6M $ | 0.24 % | as of Mar 31, 2026 ↗ |
| EQ/2000 Managed Volatility Portfolio EQ Advisors Trust | 71,541 | 1.6M $ | 0.05 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Small Cap Equity ETF American Century ETF Trust | 67,222 | 2M $ | 0.08 % | as of Feb 28, 2026 ↗ |
| Nuveen Equity Index Fund TIAA-CREF Funds | 67,053 | 1.7M $ | 0.00 % | as of Apr 30, 2026 ↗ |
| First Trust US Equity Opportunities ETF First Trust Exchange-Traded Fund | 65,436 | 1.4M $ | 0.12 % | as of Mar 31, 2026 ↗ |
| Nuveen Quant Small Cap Equity Fund TIAA-CREF Funds | 64,400 | 1.6M $ | 0.04 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Small Cap Value Insights Fund Goldman Sachs Trust | 53,936 | 1.3M $ | 0.12 % | as of Apr 30, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 52,263 | 1.2M $ | 0.00 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Integrated U.S. Small-Mid Cap Core Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 51,797 | 1.1M $ | 0.08 % | as of Mar 31, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 47,589 | 1.2M $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 45,966 | 1.4M $ | 0.00 % | as of Feb 28, 2026 ↗ |
| LVIP SSGA Small-Cap Index Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 45,443 | 1M $ | 0.05 % | as of Mar 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 44,097 | 971.5K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| T.Rowe Price Small Cap Growth Portfolio Brighthouse Funds Trust II | 43,300 | 953.9K $ | 0.09 % | as of Mar 31, 2026 ↗ |
| Tax-Managed U.S. Mid & Small Cap Fund RUSSELL INVESTMENT CO | 42,362 | 1M $ | 0.05 % | as of Apr 30, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 41,766 | 1M $ | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD RUSSELL 2000 VALUE INDEX FUND VANGUARD SCOTTSDALE FUNDS | 41,565 | 1.2M $ | 0.11 % | as of Feb 28, 2026 ↗ |
| EQ/Small Company Index Portfolio EQ Advisors Trust | 40,512 | 892.5K $ | 0.06 % | as of Mar 31, 2026 ↗ |
| Royce Smaller-Companies Growth Fund ROYCE FUND | 40,000 | 881.2K $ | 0.49 % | as of Mar 31, 2026 ↗ |
| JPMorgan U.S. Small Company Fund JPMorgan Trust I | 39,577 | 871.9K $ | 0.10 % | as of Mar 31, 2026 ↗ |
| VANGUARD STRATEGIC SMALL-CAP EQUITY FUND VANGUARD HORIZON FUNDS | 38,444 | 846.9K $ | 0.03 % | as of Mar 31, 2026 ↗ |
| SmallCap Account Principal Variable Contract Funds, Inc | 37,900 | 834.9K $ | 0.49 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 32,758 | 972.6K $ | 0.01 % | as of Feb 28, 2026 ↗ |
| Small Cap Index Fund Northern Funds | 31,292 | 689.4K $ | 0.05 % | as of Mar 31, 2026 ↗ |
| Bridge Builder Small/Mid Cap Value Fund Bridge Builder Trust | 30,660 | 675.4K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| AST PGIM Aggressive Multi-Asset Portfolio Advanced Series Trust | 29,700 | 654.3K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| Global X Russell 2000 ETF GLOBAL X FUNDS | 29,676 | 732.7K $ | 0.05 % | as of Apr 30, 2026 ↗ |
| Fidelity MSCI Health Care Index ETF FIDELITY COVINGTON TRUST | 29,655 | 732.2K $ | 0.03 % | as of Apr 30, 2026 ↗ |
| Fidelity ZERO Extended Market Index Fund Fidelity Concord Street Trust | 28,377 | 700.6K $ | 0.03 % | as of Apr 30, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 26,808 | 590.6K $ | 0.26 % | as of Mar 31, 2026 ↗ |
| MML VIP Invesco Small Cap Equity Fund MML Series Investment Fund II | 26,645 | 587K $ | 0.47 % | as of Mar 31, 2026 ↗ |
| Transamerica T. Rowe Price Small Cap VP TRANSAMERICA SERIES TRUST | 26,000 | 572.8K $ | 0.09 % | as of Mar 31, 2026 ↗ |
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT CO | 25,105 | 619.8K $ | 0.06 % | as of Apr 30, 2026 ↗ |
| STATE STREET SMALL/MID CAP EQUITY INDEX PORTFOLIO STATE STREET INSTITUTIONAL INVESTMENT TRUST | 24,064 | 530.1K $ | 0.02 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 24,020 | 593.1K $ | 1.59 % | as of Apr 30, 2026 ↗ |
| Small Cap Index Fund VALIC Co I | 23,118 | 686.4K $ | 0.06 % | as of Feb 28, 2026 ↗ |
| MetLife Russell 2000 Index Portfolio Brighthouse Funds Trust II | 21,798 | 480.2K $ | 0.05 % | as of Mar 31, 2026 ↗ |
| JPMorgan Small Cap Value Portfolio Brighthouse Funds Trust I | 20,833 | 459K $ | 0.15 % | as of Mar 31, 2026 ↗ |
| VIP Disciplined Small Cap Portfolio Variable Insurance Products Fund II | 19,933 | 439.1K $ | 0.08 % | as of Mar 31, 2026 ↗ |
| PGIM Quant Solutions Large-Cap Core Fund Prudential Investment Portfolios 9 | 19,600 | 483.9K $ | 0.05 % | as of Apr 30, 2026 ↗ |
| EQ/AB Small Cap Growth Portfolio EQ Advisors Trust | 19,482 | 429.2K $ | 0.02 % | as of Mar 31, 2026 ↗ |
| ATM Small Cap Managed Volatility Portfolio EQ Advisors Trust | 19,350 | 426.3K $ | 0.04 % | as of Mar 31, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 18,625 | 410.3K $ | 0.26 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Small Cap Equity Insights Fund Goldman Sachs Trust | 18,355 | 453.2K $ | 0.06 % | as of Apr 30, 2026 ↗ |
| Small-Cap Index Portfolio PACIFIC SELECT FUND | 17,882 | 393.9K $ | 0.05 % | as of Mar 31, 2026 ↗ |
| Health Sciences Portfolio PACIFIC SELECT FUND | 17,411 | 383.6K $ | 0.11 % | as of Mar 31, 2026 ↗ |
| Small Cap Value Fund VALIC Co I | 16,817 | 499.3K $ | 0.20 % | as of Feb 28, 2026 ↗ |
| iShares Russell 3000 ETF iShares Trust | 15,169 | 334.2K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Extended Equity Market Index Fund T. ROWE PRICE INDEX TRUST, INC. | 14,500 | 319.4K $ | 0.03 % | as of Mar 31, 2026 ↗ |
| NVIT Small Cap Index Fund Nationwide Variable Insurance Trust | 13,500 | 297.4K $ | 0.05 % | as of Mar 31, 2026 ↗ |
| Diversified Equity Master Portfolio Master Investment Portfolio | 13,047 | 287.4K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| AST Large-Cap Equity Portfolio Advanced Series Trust | 12,500 | 275.4K $ | 0.02 % | as of Mar 31, 2026 ↗ |
| Small Cap Index Trust John Hancock Variable Insurance Trust | 12,419 | 273.6K $ | 0.05 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 12,314 | 271.3K $ | 0.16 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Small Cap Index Fund Fidelity Salem Street Trust | 12,205 | 301.3K $ | 0.07 % | as of Apr 30, 2026 ↗ |
| PGIM Quant Solutions Small-Cap Value Fund Target Portfolio Trust | 11,300 | 279K $ | 0.07 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| Invesco Dorsey Wright Healthcare Momentum ETF Invesco Exchange-Traded Fund Trust | 2.12 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF SPDR SERIES TRUST | 1.60 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 1.59 % | as of Apr 30, 2026 ↗ |
| PROFUND VP PHARMACEUTICALS ProFunds | 1.54 % | as of Mar 31, 2026 ↗ |
| Direxion Daily Pharmaceutical & Medical Bull 3X Shares Direxion Shares ETF Trust | 1.25 % | as of Apr 30, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 1.24 % | as of Apr 30, 2026 ↗ |
| Invesco Dorsey Wright SmallCap Momentum ETF Invesco Exchange-Traded Fund Trust II | 0.99 % | as of Feb 28, 2026 ↗ |
| Lord Abbett Health Care Fund LORD ABBETT SECURITIES TRUST | 0.66 % | as of Apr 30, 2026 ↗ |
| JPMorgan Healthcare Leaders ETF J.P. Morgan Exchange-Traded Fund Trust | 0.54 % | as of Apr 30, 2026 ↗ |
| iShares U.S. Pharmaceuticals ETF iShares Trust | 0.50 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 181 | +63 | 18,398,005 | +88.6 % |
| 2026Q1 | 118 | +13 | 9,755,875 | +11.3 % |
| 2025Q4 | 105 | -3 | 8,766,477 | +3.2 % |
| 2025Q3 | 108 | +25 | 8,496,364 | +245.2 % |
| 2025Q2 | 83 | +9 | 2,461,620 | +22.4 % |
| 2025Q1 | 74 | +18 | 2,010,995 | +37.1 % |
| 2024Q4 | 56 | 1,467,056 |
Institutional managers
188 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 7,170,868 | 158M $ | as of Mar 31, 2026 |
| Deep Track Capital, LP | 6,772,595 | 149.2M $ | as of Mar 31, 2026 |
| SAMSARA BIOCAPITAL, LLC | 6,345,219 | 139.8M $ | as of Mar 31, 2026 |
| Foresite Capital Management V, LLC | 5,896,995 | 129.9M $ | as of Mar 31, 2026 |
| venBio Partners LLC | 4,528,408 | 99.8M $ | as of Mar 31, 2026 |
| Foresite Capital Management VI LLC | 4,247,670 | 93.6M $ | as of Mar 31, 2026 |
| Cormorant Asset Management, LP | 3,949,241 | 87M $ | as of Mar 31, 2026 |
| Nextech Invest, Ltd. | 3,540,998 | 78M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3,286,753 | 72.4K $ | as of Mar 31, 2026 |
| Saturn V Capital Management LP | 3,202,075 | 70.5M $ | as of Mar 31, 2026 |
| UBS Group AG | 3,054,865 | 67.3M $ | as of Mar 31, 2026 |
| Octagon Capital Advisors LP | 2,830,700 | 62.4M $ | as of Mar 31, 2026 |
| MPM BIOIMPACT LLC | 2,386,529 | 52.6M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 2,124,408 | 46.8M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 2,012,500 | 44.3M $ | as of Mar 31, 2026 |
| SR One Capital Management, LP | 1,959,896 | 43.2M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,918,415 | 42.3M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 1,801,812 | 39.7M $ | as of Mar 31, 2026 |
| Invesco Ltd. | 1,511,537 | 33.3M $ | as of Mar 31, 2026 |
| Ikarian Capital, LLC | 1,213,548 | 26.7M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 1,172,749 | 25.8M $ | as of Mar 31, 2026 |
| Weiss Asset Management LP | 1,097,417 | 24.2M $ | as of Mar 31, 2026 |
| PRINCIPAL FINANCIAL GROUP INC | 1,058,051 | 23.3M $ | as of Mar 31, 2026 |
| FMR LLC | 973,782 | 21.5M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 861,575 | 17.4M $ | as of Mar 31, 2026 |
Declared shareholders of Alumis Inc
2 beneficial ownership filings. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Foresite Capital Fund VI LP and 11 others | 12.70 % | 15,693,820 | as of Apr 1, 2026 · SCHEDULE 13D |
| Deep Track Capital, LP and 2 others | 5.98 % | 7,362,035 | as of Mar 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Alumis Inc". https://titelia.com/en/stocks/alumis-inc-US0223071020